Doo-Il Kim
Overview
Explore the profile of Doo-Il Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jo J, Lee S, Joh H, Kim H, Kim J, Hong Y, et al.
Crit Care
. 2025 Feb;
29(1):65.
PMID: 39915828
Background: Although potent P2Y inhibitors, such as ticagrelor and prasugrel, are standard treatment in patients with acute myocardial infarction (AMI), evidence for their efficacy and safety compared with clopidogrel is...
2.
Kang J, Chung J, Park K, Bae J, Lee H, Hwang D, et al.
JAMA Cardiol
. 2024 Nov;
PMID: 39602157
Importance: Antiplatelet monotherapy in the chronic maintenance period for patients with high bleeding risk (HBR) and those who have undergone complex percutaneous coronary intervention (PCI) has not yet been explored....
3.
Soh M, Won K, Kim J, Lee S, Hyon M, Youn H, et al.
Sci Rep
. 2024 Oct;
14(1):22940.
PMID: 39358448
Effective antihypertensive therapy is essential for achieving optimal blood pressure (BP) control and reducing cardiovascular events. This double-blind, multicenter, randomized trial aimed to compare the antihypertensive efficacy and safety of...
4.
Lee H, Min K, Han K, Kim J, Ahn J, Kim M, et al.
Clin Ther
. 2024 May;
46(6):481-489.
PMID: 38704294
Purpose: This study aimed to evaluate the efficacy and tolerability of irbesartan (IRB) and amlodipine (AML) combination therapy in patients with essential hypertension whose blood pressure (BP) was not controlled...
5.
Lee J, Youn Y, Jeon H, Lee J, Ahn S, Yoon J, et al.
J Korean Med Sci
. 2024 Mar;
39(10):e111.
PMID: 38501187
Background: The benefits of transradial access (TRA) over transfemoral access (TFA) for bifurcation percutaneous coronary intervention (PCI) are uncertain because of the limited availability of device selection. This study aimed...
6.
Yoon S, Song Y, Song Y, Park J, Kim S, Kim D, et al.
Egypt Heart J
. 2024 Mar;
76(1):33.
PMID: 38498256
Background: Pregnancy-associated spontaneous coronary artery dissection (SCAD) and reversible cerebral vasoconstriction syndrome (RCVS) are rare conditions that may occur during pregnancy and the postpartum period. The coexistence of both diseases...
7.
Choi H, Lee S, Park J, Song Y, Kim D, Kim K, et al.
J Yeungnam Med Sci
. 2023 Apr;
40(4):448-453.
PMID: 37098683
Takayasu arteritis (TA) is a disease that causes inflammation and stenosis of medium to large blood vessels. We report a case of a 50-year-old female patient with newly developed hypertension,...
8.
Cha J, Hong S, Kim J, Lim S, Joo H, Park J, et al.
Front Cardiovasc Med
. 2023 Jan;
9:1018802.
PMID: 36620646
Background: Diabetes mellitus (DM) is a critical risk factor for the pathogenesis and progression of coronary artery disease, with a higher prevalence of complex coronary artery disease, including bifurcation lesions....
9.
Lee C, Nam C, Cho Y, Yoon H, Kim K, Gwon H, et al.
JACC Asia
. 2022 Nov;
1(1):53-64.
PMID: 36338374
Background: The optimal side branch (SB) treatment strategy after simple crossover stenting in bifurcation lesions is still controversial. Objectives: The purpose of this study was to compare the long-term outcomes...
10.
Choi K, Song Y, Lee J, Park T, Yang J, Hahn J, et al.
JACC Asia
. 2022 Nov;
1(1):68-79.
PMID: 36338362
Background: There is a paucity of data regarding the long-term clinical outcomes of first- versus second-generation drug-eluting stent (DES), especially when used to treat complex lesions such as bifurcation lesions....